Avista Pharma - Crunchbase Company Profile & Funding

Q: Who invested in Avista Pharma?

Avista Pharma is funded by Ampersand Capital Partners.

Q: When was the last funding round for Avista Pharma?

Avista Pharma closed its last funding round on obfuscated from a Private Equity round.

Overview

Avista Pharma

Heat Score

Company Performance Metrics

Score

Trend

About These Metrics

AI Content may contain mistakes and is not legal, financial or investment advice.

Learn more.

Growth Score - The measure of growth based on company activity, operational metrics, and investments

Growth Trend - The change in the growth score over the given time period

Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity

Heat Trend - The change in the heat score over the given time period

See more interactive data and historical milestones on desktop for the best experience

About Avista Pharma

CB Rank

639762

Avista Pharma Solutions - your capable, dependable partner - is a contract development and manufacturing

Acquired by

Cambrex

Founded

obfuscation

Private

Private Equity

Durham, North Carolina, United States

501-1000

www.avistapharma.com/

Biotechnology

Health Care

Manufacturing

Medical

Funding Rounds

Private Equity

OBF

obfuscation

Details

Legal Name

Avista Pharma Solutions, Inc.

Operating Status

Closed

Company Type

For Profit

About the Company

Avista Pharma Solutions is a contract testing, development and manufacturing organization encompassing over 200,000 square feet of laboratory and manufacturing space across three locations (Agawam, MA, Durham, NC, and Longmont, CO), providing pharmaceutical, animal health and medical device clients with a broad suite of

scientifically-differentiated services ranging from early drug development to drug product manufacturing.

Phone Number

(919)544-8600

Contact Email

sales@avistapharma.com

Predictions & Insights

Unlock More with Crunchbase Pro

Full access to financial & funding data on unlimited profiles
Export up to 2k results/month for analysis
Track market signals on competitors, products, and R&D
Preview private company insights and predictions

Financials

Company Funding

Funding Rounds

Investors

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Private Equity Round - Avista Pharma	1	obfuscated obfuscation	—	Private Equity
obfuscated obfuscation	Private Equity Round - Avista Pharma	1	obfuscated obfuscation	—	Private Equity
obfuscated obfuscation	Private Equity Round - Avista Pharma	1	obfuscated obfuscation	—	Private Equity
obfuscated obfuscation	Private Equity Round - Avista Pharma	1	obfuscated obfuscation	—	Private Equity
obfuscated obfuscation	Private Equity Round - Avista Pharma	1	obfuscated obfuscation	—	Private Equity

Funding Rounds

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Private Equity Round - Avista Pharma	1	obfuscated obfuscation	—	Private Equity
obfuscated obfuscation	Private Equity Round - Avista Pharma	1	obfuscated obfuscation	—	Private Equity
obfuscated obfuscation	Private Equity Round - Avista Pharma	1	obfuscated obfuscation	—	Private Equity
obfuscated obfuscation	Private Equity Round - Avista Pharma	1	obfuscated obfuscation	—	Private Equity
obfuscated obfuscation	Private Equity Round - Avista Pharma	1	obfuscated obfuscation	—	Private Equity

Investors

Unlock company funding data, including rounds, dates, amounts, and investors.

Investor Name	Lead Investor	Funding Round	Partners
Ampersand Capital Partners	—	Private Equity Round - Avista Pharma	—
Ampersand Capital Partners	—	Private Equity Round - Avista Pharma	—
Ampersand Capital Partners	—	Private Equity Round - Avista Pharma	—
Ampersand Capital Partners	—	Private Equity Round - Avista Pharma	—
Ampersand Capital Partners	—	Private Equity Round - Avista Pharma	—